Hyderabad: Karkinos Healthcare, a technology-driven, oncology-focused managed healthcare platform, today launched the “Advanced Center for Cancer Diagnosis and Research” in Kochi. The center was inaugurated by the Honorable Chief Minister of Kerala, Shri. Pinarayi Vijayan. Other dignitaries present at the event were: Shri. P. Rajeev, Honorable Minister of Industries, Law and Coir, Government of Kerala and Prof. Mohanan Kunnummal, Vice-Chancellor, Kerala University of Health Sciences.
Advanced Center for Cancer Diagnostics offerings:
v Premier oncology lab for comprehensive cancer diagnostic services including cytology, molecular pathology, liquid biopsy and whole genome sequencing
v Digital Pathology cutting the geographical barrier
v Companion Diagnostics for precision targeted therapy – with Molecular Tumor Board
v Application of artificial intelligence and data science in cancer diagnosis and response to treatment
v Affordable services with global quality standards
v Training – short-term courses and fellowship to pass on know-how to next generation lab experts
The Advanced Cancer Diagnostics and Research Center will serve as the central laboratory for Karkinos’ global oncology network, analyzing samples at the molecular and genomic level to aid in personalized targeted therapy, predicting possible response to treatment, and assessing the liquid biopsy response.
While presenting the outline of the facility to the dignitaries, Dr. Moni Abraham Kuriakose, Co-Founder, Medical Director and CEO – Kerala Operations, Karkinos Healthcare said, “Advanced Center for Cancer Diagnostics and Research is the research laboratory dedicated team of Karkinos Healthcare that strives to create solutions for the future through innovation.The focus is on early diagnostic tools, molecular testing for precision medicine, which are not readily available in Karkinos Healthcare strives to create an India-specific cancer genomic tumor panel and support other clinicians, scientists and academic organizations in various applied research programs.
Commenting on the occasion, Mr. Sundar Raman, Co-Founder of Karkinos Healthcare, said, “The estimated number of new cancer patients in India is 13.2 lakhs and the current number of cancer patients is triple. of this number. The disaster is that diagnoses occur at a late stage, which increases the cost of treatment and reduces the cure rate. Karkinos is attempting to bring synergy in distributed healthcare infrastructure through technology, so that cancer screening can be done at the community level and patient care becomes coordinated and seamless through the Karkinos command center . Karkinos Healthcare’s vision is to improve the experience of cancer care and cure.
Today, with the launch of the Advanced Cancer Diagnostics and Research Center, we’ve added another crucial step to that journey – which will function as the central nervous system for Karkinos Healthcare’s 12-state and growing operations. exponential.
Karkinos Healthcare has installed in this center the most advanced high-throughput HPV testing equipment, the Cobas 6800, with the capacity to test more than 1200 human papillomavirus (HPV) tests of all high-risk types. Karkinos Healthcare has partnered with professional organizations such as the Kerala Federation of Obstetrics and Gynecology (KFOG) to support the World Health Organization’s mission to eliminate cervical cancer from here 2030.
Karkinos Healthcare, a pioneer of the distributed cancer care network model in India, counts Ratan Tata, Venu Srinivasan, Kris Gopalakrishnan, Ronnie Screwvala, Vijay Shekar Sharma and Bhavish Agarwal among its investors. Tata Group is investing Rs. 110 crore in Karkinos while Rakuten Medical, the global clinical-stage biotechnology company, Mayo Clinic and Reliance Digital Health hold minority stakes. Venture capital fund Endiya Partners also has a stake in the company.
Karkinos Healthcare launched its oncology services in Idukki district of Kerala from April 2021 and has since expanded to Ernakulam, Thrissur, Thiruvananthapuram, Malappuram and Kasaragod. In Kerala, Karkinos has established 11 units in existing multi-specialty hospitals and plans to add 63 more centers by FY23.
Karkinos Healthcare has now expanded into Tamil Nadu, Karnataka, Andhra Pradesh, Telangana, Maharashtra, Madhya Pradesh, West Bengal, Manipur and Delhi NCR and is stepping up operations across India with aims to develop 400 community cancer centres. Despite the pandemic restrictions, Karkinos Healthcare network assessed the risk of 1 Lakh+ citizen, 15,000 were found to be high risk and underwent standardized cancer screening services in its network. The company is a member of the National Cancer Grid, a group of more than 260 cancer-focused institutions. Karkinos Healthcare is also setting up a cancer center at the premises of the Jawaharlal Nehru Institute of Medical Sciences (JNIMS) in Imphal, in partnership with the government of Manipur.